Galectin-1 Promotes Gastric Carcinoma Progression and Cisplatin Resistance Through the NRP-1/c-JUN/Wee1 Pathway-Reference-Cited by-同舟云学术

Galectin-1 Promotes Gastric Carcinoma Progression and Cisplatin Resistance Through the NRP-1/c-JUN/Wee1 Pathway

Published:2024 Issue:3 Volume:24 Page:300
ISSN:2093-582X
Container-title:Journal of Gastric Cancer
language:en
Short-container-title:J Gastric Cancer

Author:

Pan Zhengyang¹²^ORCID,Xu Guoxi³^ORCID,Zhang Yan²^ORCID,Wu Meiling⁴^ORCID,Yu Jiahui²^ORCID,He Xujun²^ORCID,Zhang Wei¹^ORCID,Hu Junfeng⁴^ORCID

Affiliation:

1. Department of Gastrointestinal surgery, Zhejiang Chinese Medical University, Hangzhou, China.

2. Cancer Center, Department of Genetic and Genomic Medicine, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, China.

3. Department of Gastrointestinal Surgery, Jinjiang Hospital, Quanzhou, China.

4. General Surgery, Cancer Center, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, China.

Funder

Natural Science Foundation of Zhejiang Province

Medicine and Health Research Foundation of Zhejiang Province

Zhejiang Traditional Chinese Medicine Science and Technology Plan

Zhejiang Health Commission Fund

Publisher

XMLink

Link

https://jgc-online.org/pdf/10.5230/jgc.2024.24.e25

Reference30 articles.

1. Gastric cancer

2. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer

3. Targeting CAFs to overcome anticancer therapeutic resistance

4. Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway

5. Galectin‑1 binds GRP78 to promote the proliferation and metastasis of gastric cancer